Skip to main content
. 2001 Aug;39(8):2924–2927. doi: 10.1128/JCM.39.8.2924-2927.2001

TABLE 2.

Testing volume by technology type

Technique No. (%) of labs performing testa Median no. of tests performed (range) No. of tests performed (% of all tests performed) No. of positive tests (% of total no. of positive tests) % Positive (range) Median charge per test (US$) (range)
LCR 16 (23) 4,320 (265–42,322) 113,624 (35.7) 5,198 (41.9) 4.6 (1.4–8.4) 42 (7.9–62)b
DNA probe 10 (13) 6,205 (40–30,334) 91,909 (28.9) 3,203 (25.8) 3.5 (2.4–7.5) 35.50 (6–46)c
EIA 19 (28) 1,820 (29–25,736) 63,841 (20.1) 2,084 (16.8) 3.3 (0.8–4.7) 32.19 (15.50–64.6)d
Culture 5 (8) 773 (178–34,393) 37,502 (11.8) 1,541 (12.4) 4.1 (2.3–5) 67.55 (38.90–104)e
Direct fluorescent antibody 12 (13) 184 (15–4,661) 9,377 (2.9) 297 (2.4) 3.2 (0–8.6) 36 (21–86)f
Rapid test 11 (15) 160 (6–489) 1,880 (0.6) 72 (0.6) 3.8 (0–6.9) 37 (19–45)
 Total 60 (100) 1,139 (6–53,045) 318,133 12,395 4.0 (0–8.6) 38.0 (7.9–104)
a

Some laboratories performed more than one type of test. 

b

No charge was defined for 42,322 tests performed in a public health laboratory. 

c

No charge was defined for 7,089 tests performed in private or hospital laboratories and 6,205 tests performed in a military laboratory. 

d

No charges were defined for 25,736 tests performed in a hospital lab and 22,486 tests performed in other labs. 

e

No charge was defined for 773 tests performed in a lab. 

f

No charge was defined for 143 tests performed in labs.